# Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

> **NCT06424470** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 200 (actual)

## Conditions studied

- Prurigo Nodularis

## Interventions

- **BIOLOGICAL:** Stapokibart
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06424470
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06424470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06424470, "Study on the Treatment of Prurigo Nodularis With Stapokibart Injection". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06424470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*